Table: Taisho Pharmaceutical HD -6-MTH group results
Oct 31 (Reuters)-
Taisho Pharmaceutical Holdings Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2016 Sep 30, 2015 Mar 31, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 141.01 145.98 285.00
(-3.4 pct) (+2.9 pct) (-1.8 pct)
Operating 16.66 13.93 29.50
(+19.6 pct) (-14.2 pct) (+2.2 pct)
Recurring 19.13 17.68 36.50
(+8.2 pct) (-9.7 pct) (-0.7 pct)
Net 13.50 11.28 24.00
(+19.7 pct) (-10.4 pct) (+6.8 pct)
EPS 168.93 yen 139.16 yen 300.37 yen
EPS Diluted 168.82 yen 139.09 yen
Ann Div 100.00 yen 110.00 yen
-Q2 div 50.00 yen 50.00 yen
-Q4 div 50.00 yen 60.00 yen
NOTE - Taisho Pharmaceutical Holdings Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on Taisho Pharmaceutical Holdings Co
See all newsBrief: Curi RMB Capital, Kaname Capital To Request Tokyo Court To Revise Taisho Pharmaceutical's Squeeze Out Price If Taisho Disagrees With Their Demand - Nikkei
Brief: Curi RMB Capital, Kaname Capital To Request Tokyo Court To Revise Taisho Pharmaceutical's Tender Offer Price If Taisho Disagrees Their Demand - Nikkei
Activist fund Oasis says it may take legal action over Taisho's management buyout
Brief: Curi RMB Capital Opposes Taisho Pharmaceutical HD's Management Buyout
To Retire Treasury Shares Worth 3.65% Of Outstanding Stock On April 10